Physician
Nguyen, Tuan
Nguyen, Tuan was paid $2.55M by Medicaid between Jun 2018 and Dec 2024, across 50 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 22% of everything it billed.
33Billing provider infoNGUYEN, TUAN
HOUSTON, TX 77072
HOUSTON, TX 77072
33aNPI1457330029assigned 01/12/2006
33bProvider typePediatrics Physician
28Total paid$2.55M
24GClaims105,702
24DCodes billed50
24AFirst – last monthJun 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Texas
Rank by total paid#186 of 1,136
Median peer was paid$329K
This provider vs. median7.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 89 | $2K | |
| 2019 | 1,541 | $27K | |
| 2020 | 11,687 | $245K | |
| 2021 | 28,828 | $675K | |
| 2022 | 27,544 | $656K | |
| 2023 | 20,982 | $535K | |
| 2024incomplete | 15,031 | $414K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 22% | 14,541 | 13,129 | $564K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 16% | 7,666 | 7,299 | $421K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 12% | 3,354 | 3,279 | $319K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 11% | 11,283 | 10,817 | $280K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 11% | 3,173 | 3,116 | $276K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 7.4% | 18,845 | 10,772 | $189K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 5.2% | 1,599 | 1,578 | $134K |
| 92552 | 2.0% | 4,862 | 4,754 | $50K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.8% | 876 | 844 | $47K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.5% | 479 | 474 | $39K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 1.1% | 299 | 294 | $28K |
| 99000 | <1% | 2,284 | 2,107 | $25K |
38 more codes
| 86580 | <1% | 1,952 | $16K | |
| 0001A | <1% | 353 | $15K | |
| 97803 | <1% | 8,358 | $15K | |
| 0071A | <1% | 357 | $14K | |
| 0002A | <1% | 338 | $14K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 903 | $14K |
| 0072A | <1% | 333 | $13K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 913 | $13K |
| 90621 | <1% | 563 | $12K | |
| 90461 | <1% | 2,195 | $11K | |
| 90651 | <1% | 2,534 | $10K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 159 | $10K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 406 | $6K |
| 90686 | <1% | 4,410 | $5K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 295 | $4K |
| 0003A | <1% | 97 | $4K | |
| 90620 | <1% | 165 | $2K | |
| 81002 | <1% | 727 | $2K | |
| 90672 | <1% | 511 | $869.47 | |
| 90734 | <1% | 1,198 | $813.94 | |
| 90656 | <1% | 211 | $286.09 | |
| 90670 | <1% | 693 | $227.66 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 20 | $224.44 |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 13 | $110.68 |
| 90707 | <1% | 426 | $88.20 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 37 | $38.66 |
| 90715 | <1% | 402 | $32.00 | |
| 91307 | 0% | 699 | $0.00 | |
| 90680 | 0% | 121 | $0.00 | |
| 90716 | 0% | 453 | $0.00 | |
| 94760 | 0% | 16 | $0.00 | |
| 97802 | 0% | 12 | $0.00 | |
| 91300 | 0% | 835 | $0.00 | |
| 90700 | 0% | 600 | $0.00 | |
| 99173 | 0% | 4,220 | $0.00 | |
| 90633 | 0% | 373 | $0.00 | |
| 90648 | 0% | 252 | $0.00 | |
| 90713 | 0% | 291 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.